Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Cash Flow Quality Index
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Cash Flow Quality Index of -4.05x as of March 2025. Operating cash flow of CN¥-98.63 Million is below net income of CN¥24.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hainan Huluwa Pharmaceutical Group Co Lt debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hainan Huluwa Pharmaceutical Group Co Ltd Cash Flow Quality Index (2016–2023)
Historical Cash Flow Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 605199 cash generation efficiency.
Annual Cash Flow Quality Index for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2023)
Year-by-year earnings quality comparison for Hainan Huluwa Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.27x | CN¥28.25 Million | CN¥106.50 Million | ▼ -90.6% |
| 2022 | 2.82x | CN¥238.71 Million | CN¥84.74 Million | ▲ +91.2% |
| 2021 | 1.47x | CN¥102.48 Million | CN¥69.56 Million | ▲ +5325.1% |
| 2020 | 0.03x | CN¥3.30 Million | CN¥121.50 Million | ▼ -97.7% |
| 2019 | 1.20x | CN¥144.51 Million | CN¥120.33 Million | ▲ +279.7% |
| 2018 | 0.32x | CN¥31.80 Million | CN¥100.54 Million | ▼ -92.2% |
| 2017 | 4.07x | CN¥89.96 Million | CN¥22.13 Million | ▲ +111.3% |
| 2016 | 1.92x | CN¥64.96 Million | CN¥33.76 Million | — |